Abstract
Interferon β (INFβ) and glatiramer acetate (GA) are widely used in patients with relapsing–remitting multiple sclerosis (RRMS). However, it is still unclear whether they have different efficacy. We performed a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have